Mechanisms of Angle Development and Glaucoma
About the Research Project
Program
Award Type
Standard
Award Amount
$200,000
Active Dates
July 01, 2021 - June 30, 2024
Grant ID
G2021007S
Goals
Using a mouse model of early-onset glaucoma, we aim to understand the development of eye structures responsible for maintaining eye pressure.
Summary
Glaucoma is the second leading cause of blindness in the United States and affects nearly 80 million people worldwide. Glaucoma results from increased pressure in the eye. Drainage structures in the eye regulate this pressure. In several cases of glaucoma and especially early-onset glaucoma, drainage structures are affected. To address this, we need to understand the genetics of drainage structure development. We have developed a mouse model of early-onset glaucoma. Using this mouse model and modern imaging methods, we will determine how drainage structures develop. We will also determine the mechanism through which abnormalities in drainage tissue cause early-onset glaucoma using modern molecular tools. A mechanistic understanding will lead to the development of new treatment targets for early-onset glaucoma.
Unique and Innovative
We will provide the first genome-wide molecular characterization of normal drainage structure development by combining use of a genetic mouse model, high resolution 3-D imaging, and single cell transcriptomics.
Foreseeable Benefits
Outcomes of this study will provide a cellular level detail of the molecular control of ocular drainage structure development. This foundational information will contribute to the development of therapeutic targets for treatment of different types of glaucoma.
Related Grants
National Glaucoma Research
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
Developing New Drugs for Glaucoma
Active Dates
January 01, 2026 - December 31, 2027
Principal Investigator
Pete Williams, PhD
Current Organization
Karolinska Institutet
National Glaucoma Research
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
Maldevelopment of Schlemm's Canal in Children with Glaucoma
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Revathi Balasubramanian, PhD
Current Organization
Columbia University
National Glaucoma Research
Novel Visualization of Aqueous Outflow: Uncovering Glaucoma Mechanisms and Therapeutic Targets
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Tyson Kim, MD, PhD
Current Organization
University of California, San Francisco
Novel Visualization of Aqueous Outflow: Uncovering Glaucoma Mechanisms and Therapeutic Targets
Active Dates
July 01, 2026 - June 30, 2028
Principal Investigator
Tyson Kim, MD, PhD
Current Organization
University of California, San Francisco